Krill and Entresto drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Krill (krill oil) and Entresto (sacubitril; valsartan). Common drug interactions include back pain among females and hypotension among males.

The phase IV clinical study analyzes what interactions people have when they take Krill and Entresto. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Krill?

Krill has active ingredients of krill oil. It is often used in high blood cholesterol. eHealthMe is studying from 5,404 Krill users. Check the latest studies of Krill.

What is Entresto?

Entresto has active ingredients of sacubitril; valsartan. eHealthMe is studying from 126,628 Entresto users. Check the latest studies of Entresto.

On Jul, 10, 2026

38 people who take Krill and Entresto together, and have interactions are studied.

What are the common drug interactions of Krill and Entresto, by gender? *:

female:

Back pain
Cardiac disorder
Cataract (clouding of the lens inside the eye)
Cerebral disorder (brain disease)
Hypersensitivity
Infusion site haemorrhage (bleeding from infusion site)
Neck pain
Sinusitis (inflammation of sinus)
Blood pressure decreased
Pleural effusion (water on the lungs)

male:

Hypotension (abnormally low blood pressure)
Asthenia (weakness)
Infection
Sleep disorder
Blood glucose increased
Blood pressure decreased
Bone pain
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Abdominal pain
Back disorder

What are the common drug interactions of Krill and Entresto, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Asthenia (weakness)
Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Dyspnoea (difficult or laboured respiration)
Ejection fraction decreased (systolic heart failure)
Heart injury
Heart rate increased
Heart rate irregular
Memory impairment
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

50-59:

Death
Decreased appetite
Hot flush (sudden feelings of heat)
White blood cell count decreased

60+:

Back pain
Cardiac disorder
Pleural effusion (water on the lungs)
Blood pressure decreased
Dizziness
Fatigue (feeling of tiredness)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Abdominal distension
Abdominal pain
Bone pain

What are the existing conditions these people have? *

Cardiac Disorder: 4 people, 10.53%
Sinusitis (inflammation of sinus): 3 people, 7.89%
Immunodeficiency Common Variable: 3 people, 7.89%
Heart Attack: 3 people, 7.89%
Cardiac Failure: 3 people, 7.89%
Type 2 Diabetes: 2 people, 5.26%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 5.26%
Prostate Cancer: 2 people, 5.26%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.26%
Cardiac Failure Chronic: 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Krill and Entresto?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously